TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05517460

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Auricular acupressure
Description: The participant in Intervention period will receive acupressure on ear Shenmen point, ear Large intestine point, ear Rectumn point and ear San Jiao point.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Auricular acupressure
Description: The participant in Intervention period will receive acupressure on ear Shenmen point, ear Large intestine point, ear Rectumn point and ear San Jiao point.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: health education
Description: health education for self-care and medication adherence

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: health education
Description: health education for self-care and medication adherence
Study: NCT06242444

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Experimental Dentifrice
Description: Dentifrice containing 1150 ppm fluoride and 5% KNO3.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control Dentifrice
Description: Dentifrice containing 0 ppm fluoride and 5% KNO3.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Reference Dentifrice
Description: Dentifrice containing 1100 ppm fluoride as SnF2.
Study: NCT05962346

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BALT GOLDBALL 2 detachable latex ballon
Description: Inflated with fluid in the fetal trachea and provide with the occlusion necessary to promote lung growth.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BALTACCIBDPE100 Microcatheter
Description: Used to deliver the detachable balloon

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Storz fetoscopic operating sheath and miniature telescope/fetoscope
Description: Used to percutaneously enter though the maternal abdominal wall, uterus and into the amniotic cavity, fetal mouth, pharynx, larynx, into the trachea where the delivery catheter will be used to deliver the detachable balloon that will provide with the tracheal occlusion.
Study: NCT06195046

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Baroreflex Activation Therapy (BAT)
Description: activation of BAROSTIM NEO system that affects autonomic modulation with BAT therapy.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Baroreflex Activation Therapy (BAT)
Description: activation of BAROSTIM NEO system that affects autonomic modulation with BAT therapy.
Study: NCT04681677

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation: Intra-operative Radiation Therapy - IORT
Description: Single fraction, Intra-operative Radiation Therapy at the time of surgical resection of recurrent GBM followed by Bevacizumab 28-56 days after surgery.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Bevacizumab
Study: NCT06048796

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Early cessation of sedation and TTM
Description: Early cessation of sedation and TTM, with subsequent weaning from mechanical ventilation if appropriate
Study: NCT06663293

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Conventional Nasal Cannula
Description: The initial flow rate for nasal cannula oxygen was set at 3 L/min. In cases of hypoxia, the oxygen concentration was adjusted by increasing the flow rate by 1 to 2 L/min.
Study: NCT06510478

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Group Life Skill Intervention
Description: This 13-session life skills program covers essential topics in one-hour sessions. It starts with introductions and team building, then progresses through leadership, self-esteem, communication, stress management, positive thinking, confidence building, volunteering, decision-making, problem-solving, conflict resolution, and negotiation. Each session includes ice-breakers, discussions, and targeted exercises. Each session incorporates ice-breakers, open discussions, and targeted exercises to ensure active learning and skill internalization. Duration of each session was 1 hour.
Study: NCT06663293

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High-flow nasal cannula
Description: The high-flow nasal oxygenation device was set to a temperature of 36°C and an FiO2 of 0.4. The initial oxygen flow rate for the high flow group was determined according to the age and weight of the patients, based on our pediatric intensive care team's guidelines and the reference from the Slain study. When SpO2 fell below 94%, it was considered hypoxia, and the flow rate was increased by 2 to 4 L/min.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: midazolam, ketamine, propofol
Description: Sedation was done with IV midazolam 0.025 to 0.1 mg/kg, IV ketamine 0.25 to 0.5 mg/kg, and IV propofol (1%) 0.25 to 0.5 mg/kg
Study: NCT06510478

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Treatment as Usual for Control Group
Description: Standard psychological interventions i.e. Debreathing, Meditation, supportive counseling, or psychoeducation.
Study: NCT06663293

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: midazolam, ketamine, propofol
Description: Sedation was done with IV midazolam 0.025 to 0.1 mg/kg, IV ketamine 0.25 to 0.5 mg/kg, and IV propofol (1%) 0.25 to 0.5 mg/kg
Study: NCT05630989

Intervention type: OTHER
Intervention: combination therapy with no MEKi
Description: This cohort will receive combination therapy with no MEKi.

Intervention type: DRUG
Intervention: combination therapy with MEKi-HCQ
Description: This cohort will receive combination therapy with MEKi-HCQ.

Intervention type: DRUG
Intervention: combination therapy with MEKi-EGFRi
Description: This cohort will receive combination therapy with MEKi-EGFRi.

Intervention type: DRUG
Intervention: combination therapy with MEKi.
Description: This cohort will receive combination therapy with MEKi.
Study: NCT06663293

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Propofol
Description: Sedation maintenance was done by propofol 0.5 to 1 mg/kg/h

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: Sedation maintenance was done by propofol 0.5 to 1 mg/kg/h
Study: NCT04606550

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Microablative Fractional CO2 Laser Therapy
Description: Microablative Fractional CO2 Vaginal Laser Therapy

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Microablative Fractional CO2 Laser Therapy
Description: Microablative Fractional CO2 Vaginal Laser Therapy

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Microablative Fractional CO2 Laser Therapy
Description: Microablative Fractional CO2 Vaginal Laser Therapy
Study: NCT05785767

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fianlimab
Description: Every three weeks (Q3W) as intravenous (IV) co-infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fianlimab
Description: Every three weeks (Q3W) as intravenous (IV) co-infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cemiplimab
Description: Q3W as IV co-infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cemiplimab
Description: Q3W as IV co-infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cemiplimab
Description: Q3W as IV co-infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Q3W as IV co-infusion
Study: NCT06672575

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivonescimab
Description: Participante will recived an infusion by vein
Study: NCT06586164

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Targeted Cognitive Training
Description: TCT is a computer-based cognitive training program in which participants train on progressively more difficult auditory processing exercises in order to improve speed, accuracy and fidelity of auditory information processing in order to generate gains in cognition and functioning.
Study: NCT05970796

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Pelvic floor muscle training
Description: The pelvic floor muscle training program will be provided via an intra-vaginal biofeedback device - Smart Kegel Trainer, which will be connected to the product application installed on the mobile phone or tablet so the participants can monitor their pelvic floor contractions in real time and directly in the application. Participants will be asked to complete three sets of 8 to 12 maximal pelvic floor muscle contractions and three to ten fast contractions per training session. The home program will be tailored to each participant and include pelvic floor safe exercises recommended by the Continence Foundation of Australia.
Study: NCT04737057

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SDF
Description: Apply this topical medication through : 1)Dry with a gentle flow of compressed air to decayed tooth surfaces. 2) Bend micro sponge brush to remove excess liquid before application apply SDF directly to only the affected tooth surface. 3) Apply the SDF material 4)Dry with a gentle flow of compressed air for at least one minute. and Remove excess SDF with gauze
Study: NCT05877339

Intervention type: DIAGNOSTIC_TEST
Intervention: Survey
Description: Survey

Intervention type: DIAGNOSTIC_TEST
Intervention: Survey
Description: Survey

Intervention type: DIAGNOSTIC_TEST
Intervention: Survey
Description: Survey
Study: NCT06230094

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: moderate intensity
Description: Arm Circles, Leg Swings, Lunges, brisk walk

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: high intensity
Description: Arm circles, Leg swings, Lunges, skipping rope
Study: NCT05900648

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Regorafenib
Description: Given by PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XmAb20717
Description: Given by (IV) vein
Study: NCT05187065

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The mobile-based education and exercise program
Description: Starting from the preoperative period, mobile-based patient education, progressive relaxation exercise and knee exercise program will be applied to the patient as a whole. Mobile-based education will include pre-operative and discharge education. The patient will be given a progressive relaxation exercise with the support of the mobile application and the exercises included in the knee exercise program that should be done after the surgery will be shown. Progressive relaxation exercises will be applied twice a day in the afternoon and evening. Postoperative knee exercises will be performed 3 to 5 times a day, depending on the type of exercise. These exercises will be continued regularly for up to 4 weeks after discharge.
Study: NCT06412861

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine
Description: 0.5 mg/kg ketamine + 1 mg/kg propofol, Ramsey Sedation Score \> 4 will be targeted. For this, if necessary, additional iv 0.5 mg/kg propofol will be administered.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl
Description: 1 mcg/kg fentanyl + 1 mg/kg propofol will be administered. Ramsay Sedation Score will be targeted to be \> 4. For this, if necessary, additional iv 0.5 mg/kg propofol will be administered.
Study: NCT04447313

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Survey Administration
Description: Ancillary studies

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telephone-Based Intervention
Description: Receive ACT telephone coaching

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Telephone-Based Intervention
Description: Receive SBT telephone coaching
Study: NCT05866588

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical, psychological and spiritual nursing care (Nursing Therapeutics)
Description: 1. Follow-up: To make a presentation about the physiological and psychological changes during pregnancy. do dream work~2. Follow-up: Providing education and counseling for childbirth.~3. Follow-up: Training and role rehearsal on mother-infant interaction, breastfeeding and infant care.~4. Follow-up: To provide counseling on the issues needed with the approaching of the birth.~5. Follow-up: Teaching about conscious parenting and mother-infant, father-infant interaction.~6. Tracking. To provide education, counseling and social support on the other roles of the mother in life such as wife role, working woman role, social role.~7. Follow-up: To evaluate the transition to motherhood.~8. Follow-up: To evaluate the outcomes of transition to motherhood and adjustment to motherhood according to expected completion time.
Study: NCT05625412

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986360
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986360
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986360
Description: Specified dose on specified days
Study: NCT05970796

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training
Description: The pelvic floor muscle training program will be provided via an intra-vaginal biofeedback device - Smart Kegel Trainer, which will be connected to the product application installed on the mobile phone or tablet so the participants can monitor their pelvic floor contractions in real time and directly in the application. Participants will be asked to complete three sets of 8 to 12 maximal pelvic floor muscle contractions and three to ten fast contractions per training session. The home program will be tailored to each participant and include pelvic floor safe exercises recommended by the Continence Foundation of Australia.
Study: NCT06688812

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Perceptual Motor Training
Description: 8 set of exercises~1. Balance training and related exercises~2. Tones of awareness training, body parts' role and related exercises~3. Space awareness training and related exercises~4. Perception of shape training and related exercises~5. Visual perception training and related exercise.~6. Kinesthetic-tactile perception training and related exercises~7. Auditory perception training and related exercises~8. Eye and hand coordination, ﬁne motor movements and related Exercises
Study: NCT04737057

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: SDF
Description: Apply this topical medication through : 1)Dry with a gentle flow of compressed air to decayed tooth surfaces. 2) Bend micro sponge brush to remove excess liquid before application apply SDF directly to only the affected tooth surface. 3) Apply the SDF material 4)Dry with a gentle flow of compressed air for at least one minute. and Remove excess SDF with gauze

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Hall technique
Description: this technique is performed through :1) Orthodontic separator being stretched between two pieces of floss, then placed between the contact points of primary molars (for five days.) 2)The correct size of crown will not impinge on the teeth on either side, and a slight 'spring back' will be felt when the PMC is gently pushed up to (but not through) the contact points and the PMC has been filled with a Riva self-cure capsule cement, extruded cement is quickly wiped away and the child is asked to keep biting on the crown for two minutes, until the cement is set, to prevent 'spring back' of the PMC from the fully seated position
Study: NCT05739708

Intervention type: OTHER
Group type: OTHER
Intervention: Questionnaires
Description: The time to complete the different questionnaires is estimated to be 60 minutes.
Study: NCT06017323

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: 1000mg/m2 IV given days 1, 8, and 15every 28 days (1 cycle)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: 1000mg/m2 IV given days 1, 8, and 15every 28 days (1 cycle)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab paclitaxel
Description: 125 mg/m2 given days 1, 8, and 15every 28 days (1 cycle)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab paclitaxel
Description: 125 mg/m2 given days 1, 8, and 15every 28 days (1 cycle)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Proglumide Dose level 1
Description: Daily dose of 1200 mg orally given as400 mg orally (PO), three times a day(TID) (dose level 1)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Proglumide Dose level 2
Description: Daily dose of 1600 mg orally given as800 mg orally (PO) twice a day (BID)(dose level 2).
Study: NCT04737057

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hall technique
Description: this technique is performed through :1) Orthodontic separator being stretched between two pieces of floss, then placed between the contact points of primary molars (for five days.) 2)The correct size of crown will not impinge on the teeth on either side, and a slight 'spring back' will be felt when the PMC is gently pushed up to (but not through) the contact points and the PMC has been filled with a Riva self-cure capsule cement, extruded cement is quickly wiped away and the child is asked to keep biting on the crown for two minutes, until the cement is set, to prevent 'spring back' of the PMC from the fully seated position
Study: NCT05459805

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: traditional chinese medicine Xuanfei-Zhike formula
Description: 200ml, bid, for 8 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: inhaled corticosteroids (ICS) and long-acting β2-agonist (LABA)
Description: one suction, q12h, for 8 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: inhaled corticosteroids (ICS) and long-acting β2-agonist (LABA)
Description: one suction, q12h, for 8 weeks
Study: NCT04971811

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Snack with energy density less than 1.5 kcal/g
Description: Snack meal with snack food having energy density less than 1.5 kcal/g

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Snack with energy density greater than 1.5 kcal/g
Description: Snack meal with snack food having energy density greater than 1.5 kcal/g
Study: NCT05669885

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sildenafil
Description: Study participants will be allocated to receive oral administration of 100 mg sildenafil.
Study: NCT06312969

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video game based training
Description: Type of intervention: Cognitive training through 3 types of video games:~* Serious games or brain-training games.~* Exer-gaming~* Skill-training games~Method of administration: The patient will receive the treatment for a period of 12 weeks, in which they will commit to use the video games of the intervention with the following pattern:~* Brain-training game: sessions of 7-12 minutes with a frequency of 4 days a week.~* Exer-gaming: sessions of 15-20 minutes 2 days a week.~* Skill-training games: sessions of 15-20 minutes 2 days a week.
Study: NCT06688812

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Repetitive Facilitation Exercises
Description: Eight set of exercises:~1. Shoulder Flexion with 90° Elbow Flexion (Supine).~2. Shoulder Horizontal Extension/Flexion with Elbow flexion (supine).~3. Complex Shoulder and Upper Limb Movements (Supine)~4. Shoulder Flexion/Abduction/External Rotation with Elbow and Forearm Supination (Supine)~5. Forearm Supination/Pronation with 90° Elbow Flexion (Sitting)~6. Wrist Extension and Forearm Pronation with Finger Extension (Supine)~7. Finger Extension with Wrist Flexion (Supine)~8. Finger Extension/Flexion with Wrist Flexion (Sitting) • Therapist facilitate the movement by rubbing, tapping and gentle stretching.
Study: NCT06685796

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BEBT-209 capsules
Description: BEBT-209 Capsules, dosage: 150mg, frequency and duration of administration: administered on days 1, 2, 8, and 9 of each cycle, with a 21-day cycle. On days 1 and 8, take orally once before dinner or twice (before breakfast and before dinner), and on days 2 and 9, take orally once before breakfast.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BEBT-209 capsules
Description: BEBT-209 Capsules, dosage: 150mg, frequency and duration of administration: administered on days 1, 2, 8, and 9 of each cycle, with a 21-day cycle. On days 1 and 8, take orally once before dinner or twice (before breakfast and before dinner), and on days 2 and 9, take orally once before breakfast.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin injection
Description: Carboplatin injection, dosage: AUC 2 × (creatinine clearance rate + 25), frequency and duration of administration: administered on days 1 and 8 or days 2 and 9 of each cycle, with a 21-day cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin injection
Description: Carboplatin injection, dosage: AUC 2 × (creatinine clearance rate + 25), frequency and duration of administration: administered on days 1 and 8 or days 2 and 9 of each cycle, with a 21-day cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin injection
Description: Carboplatin injection, dosage: AUC 2 × (creatinine clearance rate + 25), frequency and duration of administration: administered on days 1 and 8 or days 2 and 9 of each cycle, with a 21-day cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine hydrochloride for injection
Description: Gemcitabine hydrochloride for injection, dosage: 1000mg/m², frequency and duration of administration: administered on days 1 and 8 or days 2 and 9 of each cycle, with a 21-day cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine hydrochloride for injection
Description: Gemcitabine hydrochloride for injection, dosage: 1000mg/m², frequency and duration of administration: administered on days 1 and 8 or days 2 and 9 of each cycle, with a 21-day cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine hydrochloride for injection
Description: Gemcitabine hydrochloride for injection, dosage: 1000mg/m², frequency and duration of administration: administered on days 1 and 8 or days 2 and 9 of each cycle, with a 21-day cycle.